Publications & News

WilmerHale Counsels Braintree Laboratories in Acquisition by Sebela Pharmaceuticals

May 10, 2018

On May 1, 2018, Sebela Pharmaceuticals completed the acquisition of Braintree Laboratories Inc., a privately held specialty pharmaceutical company based in Braintree, Massachusetts. Braintree develops, manufactures and markets specialty pharmaceuticals in gastroenterology.

The WilmerHale deal team that counseled Braintree was led by Stuart Falber and included Keith Barnett, Steven Barrett, Robert Burke, Bill Caporizzo, Joseph Conahan, Julie Hogan Rodgers, Paul Jakubowski, Jeff Johnson, Rachael Kent, Amy Null, Justin Ochs, Hartmut Schneider, Laura Schneider, John Sigel, Kimberly Wethly, Brett Jackson, Nicolette Anagnos and Ben Kelsey

Read the press release to learn more.